Moolec Science S.A. (MLEC) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Luxembourg, Luxembourg. 現CEOは Alejandro Antalich.
MLEC を有する IPO日 2021-03-02, 52 名の正社員, に上場 NASDAQ Global Market, 時価総額 $5.38M.
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
